Skip to main content
Peptides Publishing

Research Radar

Recently reviewed peptide signals, ranked for triage. Filter by goal, risk, and recency to focus quickly, then open source links for full context.

Showing 60 of 86 reviewed profiles

Feb 20, 2026Evidence 9.0/10Elevated

WOLVERINE STACK

What it does: Coverage is focused on recovery, skin and tissue repair, and performance, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as inform...

Recovery 10.0Skin & repair 7.1
Feb 20, 2026Evidence 9.0/10Moderate

VIP PEPTIDE

What it does: Coverage is focused on cognition, weight management, and healthy aging, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informat...

Cognition 7.1Weight loss 6.0
Feb 20, 2026Evidence 9.5/10Moderate

VILON

What it does: Coverage is focused on healthy aging, performance, and weight management, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as inform...

Longevity 8.3Performance 6.2
Feb 20, 2026Evidence 9.5/10Low

TIRZEPATIDE

What it does: Coverage is focused on weight management, cognition, and healthy aging, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informat...

Weight loss 10.0Cognition 8.3
Feb 20, 2026Evidence 9.5/10Moderate

THYMALIN

What it does: Coverage is focused on healthy aging, cognition, and recovery, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informational rat...

Longevity 8.3Cognition 7.2
Feb 20, 2026Evidence 9.8/10Very Low

TESAMORELIN

What it does: Coverage is focused on weight management, performance, and healthy aging, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as inform...

Weight loss 8.7Performance 6.3
Feb 20, 2026Evidence 9.0/10Moderate

TB-500

What it does: Coverage is focused on recovery, performance, and skin and tissue repair, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as inform...

Recovery 10.0Performance 6.0
Feb 20, 2026Evidence 7.6/10Moderate

SS-31

What it does: Coverage is focused on weight management, recovery, and healthy aging, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informati...

Weight loss 6.6Recovery 6.6
Feb 20, 2026Evidence 6.5/10Moderate

Sermorelin

What it does: Coverage is focused on performance, recovery, and weight management, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as information...

Performance 7.1Recovery 6.2
Feb 20, 2026Evidence 9.4/10Moderate

Semax

What it does: Coverage is focused on cognition, healthy aging, and recovery, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informational rat...

Cognition 10.0Longevity 6.1
Feb 20, 2026Evidence 9.0/10Very Low

SEMAGLUTIDE

What it does: Coverage is focused on weight management, cognition, and healthy aging, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informat...

Weight loss 10.0Cognition 8.1
Feb 20, 2026Evidence 6.5/10Moderate

Selank

What it does: Coverage is focused on cognition, weight management, and healthy aging, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informat...

Cognition 9.5Weight loss 4.1
Feb 20, 2026Evidence 9.5/10Moderate

RETINALAMIN

What it does: Coverage is focused on recovery, healthy aging, and cognition, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informational rat...

Recovery 7.2Longevity 6.2
Feb 20, 2026Evidence 9.4/10Low

Retatrutide

What it does: Coverage is focused on weight management, healthy aging, and recovery, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informati...

Weight loss 10.0Longevity 5.1
Feb 20, 2026Evidence 9.0/10Moderate

PT-141

What it does: Coverage is focused on cognition, weight management, and healthy aging, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informat...

Cognition 6.0Weight loss 5.0
Feb 20, 2026Evidence 9.5/10Moderate

PROSTATILEN

What it does: Coverage is focused on recovery, performance, and weight management, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as information...

Recovery 6.2Performance 6.2
Feb 20, 2026Evidence 9.5/10Low

PRAMLINTIDE

What it does: Coverage is focused on weight management, healthy aging, and recovery, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informati...

Weight loss 7.2Longevity 5.1
Feb 20, 2026Evidence 9.0/10Moderate

PINEALON

What it does: Coverage is focused on cognition, healthy aging, and weight management, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informat...

Cognition 10.0Longevity 8.1
Feb 20, 2026Evidence 9.8/10Very Low

PASIREOTIDE

What it does: Coverage is focused on weight management, healthy aging, and recovery, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informati...

Weight loss 5.2Longevity 5.2
Feb 20, 2026Evidence 7.0/10Moderate

MODIFIED GRF 1-29

What it does: Coverage is focused on weight management, cognition, and performance, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informatio...

Weight loss 6.4Cognition 6.4
Feb 20, 2026Evidence 7.3/10Elevated

Melanotan 2

What it does: Coverage is focused on weight management, skin and tissue repair, and healthy aging, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treate...

Weight loss 5.4Skin & repair 5.4
Feb 20, 2026Evidence 9.0/10Moderate

Melanotan 1

What it does: Coverage is focused on skin and tissue repair, weight management, and healthy aging, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treate...

Skin & repair 6.0Weight loss 5.0
Feb 20, 2026Evidence 8.5/10Moderate

LL-37

What it does: Coverage is focused on recovery, skin and tissue repair, and weight management, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as ...

Recovery 9.0Skin & repair 6.9
Feb 20, 2026Evidence 9.0/10Low

LIRAGLUTIDE

What it does: Coverage is focused on weight management, performance, and healthy aging, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as inform...

Weight loss 10.0Performance 6.0
Feb 20, 2026Evidence 9.8/10Low

LINACLOTIDE

What it does: Coverage is focused on weight management, healthy aging, and recovery, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informati...

Weight loss 5.2Longevity 5.2
Feb 20, 2026Evidence 8.5/10Moderate

Kisspeptin

What it does: Coverage is focused on cognition, weight management, and healthy aging, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informat...

Cognition 5.8Weight loss 4.8
Feb 20, 2026Evidence 6.9/10Moderate

Ipamorelin

What it does: Coverage is focused on weight management, recovery, and performance, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as information...

Weight loss 6.3Recovery 6.3
Feb 20, 2026Evidence 7.0/10Elevated

IBUTAMOREN (MK-677)

What it does: Coverage is focused on weight management, performance, and recovery, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as information...

Weight loss 7.4Performance 7.3
Feb 20, 2026Evidence 7.6/10Elevated

HUMANIN

What it does: Coverage is focused on healthy aging, weight management, and cognition, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informat...

Longevity 8.7Weight loss 6.6
Feb 20, 2026Evidence 9.5/10Moderate

HUMAN RELAXIN-2

What it does: Coverage is focused on recovery, weight management, and healthy aging, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informati...

Recovery 6.2Weight loss 5.1
Feb 20, 2026Evidence 9.4/10Very Low

HMG

What it does: Coverage is focused on weight management, healthy aging, and recovery, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informati...

Weight loss 5.1Longevity 5.1
Feb 20, 2026Evidence 8.1/10Moderate

HGH FRAGMENT 176-191

What it does: Coverage is focused on weight management, performance, and healthy aging, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as inform...

Weight loss 6.7Performance 5.7
Feb 20, 2026Evidence 7.1/10Moderate

Hexarelin

What it does: Coverage is focused on performance, weight management, and healthy aging, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as inform...

Performance 8.3Weight loss 5.3
Feb 20, 2026Evidence 9.5/10Very Low

HCG

What it does: Coverage is focused on weight management, cognition, and healthy aging, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informat...

Weight loss 8.3Cognition 6.2
Feb 20, 2026Evidence 9.5/10Very Low

GONADORELIN

What it does: Coverage is focused on cognition, weight management, and healthy aging, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informat...

Cognition 6.2Weight loss 5.1
Feb 20, 2026Evidence 9.5/10Moderate

GLP-1

What it does: Coverage is focused on weight management, performance, and cognition, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informatio...

Weight loss 10.0Performance 6.2
Feb 20, 2026Evidence 7.1/10Elevated

GHRP-6

What it does: Coverage is focused on performance, weight management, and recovery, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as information...

Performance 7.3Weight loss 6.4
Feb 20, 2026Evidence 6.5/10Elevated

GHRP-2

What it does: Coverage is focused on performance, weight management, and recovery, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as information...

Performance 7.1Weight loss 6.2
Feb 20, 2026Evidence 7.0/10Moderate

GHRELIN

What it does: Coverage is focused on weight management, cognition, and recovery, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informational...

Weight loss 8.5Cognition 6.4
Feb 20, 2026Evidence 9.0/10Moderate

GHK-Cu

What it does: Coverage is focused on skin and tissue repair, recovery, and healthy aging, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as info...

Skin & repair 10.0Recovery 9.2
Feb 20, 2026Evidence 9.5/10Moderate

GDF-11

What it does: Coverage is focused on healthy aging, performance, and cognition, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informational ...

Longevity 6.2Performance 6.2
Feb 20, 2026Evidence 9.2/10High

FOXO4-DRI

What it does: Coverage is focused on recovery, skin and tissue repair, and healthy aging, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as info...

Recovery 9.2Skin & repair 7.1
Feb 20, 2026Evidence 9.5/10Elevated

FOLLISTATIN 344

What it does: Coverage is focused on recovery, weight management, and performance, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as information...

Recovery 7.2Weight loss 6.2
Feb 20, 2026Evidence 9.5/10Very Low

EXENATIDE

What it does: Coverage is focused on weight management, healthy aging, and cognition, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informat...

Weight loss 10.0Longevity 7.2
Feb 20, 2026Evidence 6.2/10Moderate

Epitalon

What it does: Coverage is focused on healthy aging, cognition, and weight management, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informat...

Longevity 7.1Cognition 5.0
Feb 20, 2026Evidence 9.5/10Very Low

DULAGLUTIDE

What it does: Coverage is focused on weight management, healthy aging, and recovery, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informati...

Weight loss 10.0Longevity 5.1
Feb 20, 2026Evidence 7.3/10Moderate

DSIP (Delta Sleep-Inducing Peptide)

What it does: Coverage is focused on cognition, recovery, and weight management, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informational...

Cognition 6.5Recovery 5.4
Feb 20, 2026Evidence 8.7/10Elevated

Dihexa

What it does: Coverage is focused on cognition, weight management, and healthy aging, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informat...

Cognition 10.0Weight loss 4.8
Feb 20, 2026Evidence 9.5/10Moderate

DEMOXYTOCIN

What it does: Coverage is focused on cognition, weight management, and healthy aging, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informat...

Cognition 7.2Weight loss 5.1
Feb 20, 2026Evidence 9.8/10Very Low

DEGARELIX

What it does: Coverage is focused on performance, weight management, and healthy aging, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as inform...

Performance 6.1Weight loss 5.2
Feb 20, 2026Evidence 9.4/10Moderate

DECAPEPTIDE-12

What it does: Coverage is focused on skin and tissue repair, weight management, and healthy aging, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treate...

Skin & repair 7.2Weight loss 5.1

Radar cards are editorial summaries for education. They are not clinical guidance. Always verify against primary studies and product labeling.